Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
6.06
+0.12 (2.02%)
At close: Aug 12, 2026, 4:00 PM EDT
5.98
-0.08 (-1.32%)
After-hours: Aug 12, 2026, 7:52 PM EDT
UPC Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 27.56 | 33.59 | 29.5 | 5.29 | 5.71 | 8.08 |
Short-Term Investments | 1.49 | - | - | - | 13.15 | 13.73 |
Cash & Short-Term Investments | 29.05 | 33.59 | 29.5 | 5.29 | 18.86 | 21.8 |
Cash Growth | -13.52% | 13.88% | 458.11% | -71.98% | -13.50% | 116.77% |
Accounts Receivable | 14.96 | 13.01 | 12.91 | 11.08 | 15.18 | 15.81 |
Other Receivables | 7.18 | 2,281 | 5.67 | 1,920 | - | - |
Total Trade Receivables | 22.14 | 2,294 | 18.57 | 1,931 | 15.18 | 15.81 |
Inventory | 1.98 | 2.19 | 1.74 | 3.34 | 2.21 | 2.46 |
Other Current Assets | 2.04 | 2.53 | 1.83 | 3.64 | 5.26 | 10.4 |
Total Current Assets | 55.21 | 53.6 | 51.64 | 25.27 | 41.51 | 50.48 |
Net Property, Plant & Equipment | 3.79 | 3.58 | 3.57 | 3.7 | 4.25 | 4.68 |
Other Intangible Assets | 0.31 | 0.3 | 0.26 | 0.15 | 0.16 | 0.18 |
Long-Term Investments | 0.72 | 0.7 | 0.71 | 0.69 | 0.7 | 0.74 |
Other Long-Term Assets | 11.43 | 11.12 | 11.77 | 11.92 | 12.92 | 14.06 |
Total Assets | 71.47 | 69.3 | 67.95 | 41.72 | 59.54 | 70.14 |
Accounts Payable | 3.91 | 2.12 | 11.82 | 5.13 | 6.45 | 5.33 |
Accrued Expenses | 0.91 | 0.9 | 1.37 | 3.15 | 2.71 | 1.55 |
Short-Term Debt | 7.38 | 7.15 | 5.86 | 5.48 | 3.94 | 4.33 |
Current Portion of Long-Term Debt | - | 2.11 | - | - | - | - |
Unearned Revenue | 0.04 | 0.04 | - | - | - | - |
Other Current Liabilities | 1.41 | 0.86 | 1.27 | - | - | - |
Total Current Liabilities | 13.65 | 13.17 | 20.31 | 13.75 | 13.1 | 11.21 |
Long-Term Debt | 2.17 | - | 2.14 | - | - | - |
Total Long-Term Liabilities | 2.17 | - | 2.14 | - | - | - |
Total Liabilities | 15.82 | 13.17 | 22.45 | 13.75 | 13.1 | 11.21 |
Common Stock | 0 | 6.34 | 0.48 | 0.07 | 0.07 | 0.07 |
Additional Paid-in Capital | 69.35 | 63.01 | 53.86 | 29.28 | 29.28 | 29.28 |
Accumulated Other Comprehensive Income | -0.74 | -1.81 | -1.11 | -2.37 | -1.67 | 2.09 |
Retained Earnings | -12.96 | -11.4 | -7.73 | 1 | 18.76 | 27.5 |
Shareholders' Equity | 55.65 | 56.13 | 45.5 | 27.97 | 46.44 | 58.93 |
Total Liabilities & Equity | 71.47 | 69.3 | 67.95 | 41.72 | 59.54 | 70.14 |
Total Debt | 9.55 | 9.26 | 7.99 | 5.48 | 3.94 | 4.33 |
Net Cash (Debt) | 19.5 | 24.34 | 21.5 | -0.2 | 14.92 | 17.47 |
Net Cash Growth | -19.88% | 13.17% | - | - | -14.57% | 135.67% |
Net Cash Per Share | 34.59 | 53.38 | 1544.79 | - | - | - |
Book Value | 55.65 | 56.13 | 45.5 | 27.97 | 46.44 | 58.93 |
Book Value Per Share | 98.73 | 123.13 | 3268.89 | - | - | - |
Tangible Book Value | 55.34 | 55.83 | 45.24 | 27.82 | 46.28 | 58.76 |
Tangible Book Value Per Share | 98.18 | 122.47 | 3250.00 | - | - | - |